Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999 Apr;24(4):595-600.
doi: 10.1023/a:1022596115897.

Molecular mechanisms of lead neurotoxicity

Affiliations
Review

Molecular mechanisms of lead neurotoxicity

J Bressler et al. Neurochem Res. 1999 Apr.

Abstract

Epidemiological studies have shown a strong relationship between the level of lead in blood and bone as assessed by performance on IQ tests and other psychometric tests. Approximately 1 out of 10 children in the United States have blood lead levels above 10 microg/dl, which has been established as the level of concern. Studies on experimental animals exposed to lead after birth have shown learning deficits at similar blood lead levels. Since learning requires the remodeling of synapses in the brain, lead may specifically affect synaptic transmission. Although the molecular targets for lead are unknown, a vast amount of evidence accumulated over many years has shown that lead disrupts processes that are regulated by calcium. Our laboratory has been studying the effect of lead on protein kinase C, a family of isozymes some of which require calcium for activity. We and others have shown that picomolar concentrations of lead can replace micromolar concentrations of calcium in a protein kinase C enzyme assay. Furthermore, lead activates protein kinase C in intact cells and induces the expression of new genes by a mechanism dependent on protein kinase C. We propose that the learning deficits caused by lead are due to events regulated by protein kinase C that most likely occur at the synapse.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain Res. 1993 Jul 30;618(1):9-18 - PubMed
    1. J Pharmacol Exp Ther. 1997 Jul;282(1):172-80 - PubMed
    1. J Pharmacol Exp Ther. 1992 Nov;263(2):868-75 - PubMed
    1. Neurochem Res. 1995 May;20(5):561-9 - PubMed
    1. Brain Res. 1996 Oct 14;736(1-2):125-34 - PubMed

Publication types

LinkOut - more resources